RORC and autoimmune disease: They found that compound 50 (Figure 9) can act as an inhibitor of nuclear receptor RORγ (EC50 values ranging from 0.0014 μM to 3 μM) and in that way it can be used in the treatment of different autoimmune diseases, like Crohn’s disease or rheumatoid arthritis [113].